Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT04641234

Completed

A Study Reviewing Medical Records to Learn More About Treat-and-extend With Eylea in Patients With Neovascular Age-related Macular Degeneration (nAMD). (BELUGA)

Neovascular Age-related Macular Degeneration
NCT03646474

Completed

Single Dose Tranexamic Acid in Reducing Blood Loss During Cytoreductive Surgery and HIPEC

Cytoreductive Surgery
NCT00559936

Completed

Topical Avastin for Treatment of Corneal Neovascularization

Corneal Neovascularization
NCT01556776

Completed

A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy

Chronic Lymphocytic Leukemia
NCT03123588

Terminated

Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)

MPN (Myeloproliferative Neoplasms)
NCT04803591

Withdrawn

This is a Study to Verify if Tranexamic Acid Can Reduce the Anemia After a Femoral Shaft Fractures Surgery (ORL-ORT-023)

Femoral Shaft Fracture
NCT04196309

Completed

Effect of LOW-molecular-weight Heparin in Reducing Radial Artery Occlusion Rate After Transradial Coronary Catheterization (LOW-RAO)

Arterial Occlusion
NCT03470103

Completed

A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America (AQUILA)

Macular Degeneration
NCT02540954

Completed

Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Macular Degeneration
NCT01220245

Completed

SuperB Trial: SUrgical Versus PERcutaneous Bypass (SuperB)

Cardiovascular Diseases
NCT03345082

Completed

A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD

Neovascular Age-related Macular Degeneration
NCT00764738

Completed

Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration

Neovascular Age Related Macular Degeneration
NCT04275414

Completed

Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia (BEST-CP)

Coronavirus Infections
NCT02802098

Completed

Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast Cancer

Metastatic Breast Cancer | Bevacizumab-alone Maintenance Treatment Progression
NCT04147728

Unknown

Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases With Perilesional Edema in NSCLC (Rvision-001)

Stereotactic Body Radiation Therapy
NCT02953938

Completed

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety (ZIPANGU)

Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
NCT03386656

Completed

Efficacy and Safety of Topical Application of Tranexamic Acid for Saving Blood Losses in Patients Subjected to Prosthetic Knee Surgery (TRA)

Osteoarthritis, Knee
NCT02272413

Completed

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

Carcinoma, Non-Small-Cell Lung
NCT03521895

Completed

An Integrated Analysis of the Effectiveness of Intravitreal (IVT) Aflibercept (Eylea) in Routine Clinical Practice Based on Two Large Observational Studies (GALAXY)

Macular Degeneration
NCT01501760

Completed

Efficacy and Safety Study of Avastin to Treat Neovascularisation of the Cornea (BECONNEC)

Corneal Newvessels
NCT02811692

Completed

Study for Collection of Aflibercept Data in Routine Practice (CODEX)

Eye Diseases
NCT01397409

Completed

Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)

Age-related Macular Degeneration
NCT02040220

Completed

Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Eylea for Central Retinal Vein Occlusion (CRVO) (JPMS-CRVO)

Retinal Vein Occlusion
NCT02687204

Completed

Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients

Venous Thromboembolism | Deep Venous Thrombosis | Pulmonary Embolus
NCT02848612

Completed

Evaluation of the Amiens University Hospital Neuroradiology Anticoagulation Protocol (ANTICONEURORAD)

Aneurysm
NCT02530918

Completed

Study of DS-7080a for the Treatment of Macular Degeneration

Diabetic Macular Edema | Neovascular Age-Related Macular Degeneration
NCT02845466

Unknown

Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing

Foot Ulcer, Diabetic | Venous Ulcer
NCT03392792

Unknown

Regisry of the Stroke Patients in Assiut University Hospital

All Patients With Ischemic Cerebrovascular Stroke Aged ≥18 Years of Both Sex
NCT01281254

Terminated

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer
NCT03334513

Completed

Refractive Error and Biometry in Retinopathy of Prematurity

Retinopathy of Prematurity
NCT02396316

Completed

Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients (VEGA)

Glaucoma, Neovascular
NCT01930682

Completed

EARLY Routine Catheterization After Alteplase Fibrinolysis vs. PPCI in ST-Segment-Elevation MYOcardial Infarction (EARLY-MYO)

Acute ST-segment Elevation Myocardial Infarction
NCT01062698

Terminated

Trial and Cost Effectiveness Evaluation of Intra-arterial Thrombectomy in Acute Ischemic Stroke (THRACE)

Cerebrovascular Accident | Cerebral Stroke
NCT00143546

No longer available

Compassionate Use of Defibrotide for Patients With Veno-occlusive Disease of the Liver

Hepatic Veno-occlusive Disease
NCT03113708

Unknown

The Effect of Heparinization Due to LBW (LBWH)

Bleeding | Heparin | Heparin Overdose
NCT02585401

Completed

Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada

Diabetic Macular Edema (DME) | Age-related Macular Degeneration (AMD) | Central Retinal Vein Occlusion (CRVO)
NCT02583568

Completed

Fluorescence Guided Surgery in Breast Cancer (MARGIN)

Breast Cancer
NCT01448746

Unknown

Optimal Prophylactic Method of Venous Thromboembolism (VTE)

Venous Thromboembolism
NCT01718379

Completed

Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality.

Myelodysplastic Syndromes
NCT02368314

Completed

A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries

Deep Vein Thrombosis
NCT01569984

Completed

Radiosensitization of AVASTIN® (Bevacizumab) With Stereotactic Body Radiotherapy for Colorectal Liver Metastasis (SBRT-Avastin)

Colorectal Cancer.
NCT02780245

Completed

Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section

Postpartum Hemorrhage | Hemorrhage of Cesarean Section and/or Perineal Wound | Uterine Atony
NCT00003674

Completed

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer | Veno-occlusive Disease
NCT00751296

Terminated

Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL) (Rev-CLL)

Chronic Lymphocytic Leukaemia
NCT01314066

Withdrawn

Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS) (VEGF-ARDS)

Acute Respiratory Distress Syndrome | Severe Sepsis
NCT02450981

Withdrawn

Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration
NCT00406250

Completed

Intravitreal Bevacizumab in Agioid Streaks

Choroidal Neovascularization | Angioid Streaks
NCT01133223

Withdrawn

Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke

Stroke
NCT01635803

Unknown

Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO) (BRVO)

Retinal Vein Occlusion
NCT01854476

Unknown

Safety and Efficacy Study Comparing Pad-gauze With Anti-fibrinolytic Agent Hemostopan™) to a Regular Pad-gauze

Bleeding | Coagulopathy

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations